This site uses cookies to improve your experience. By viewing our content, you are accepting the use of cookies. To help us insure we adhere to various privacy regulations, please select your country/region of residence. If you do not select a country we will assume you are from the United States. View our privacy policy and terms of use.

Remove fda-committee-set-discuss-strain-selection-next-round-covid-19-boosters
Remove Pharma Related Topics
Pharma Rep Pharma reps Biopharma Pharma sales reps Pharmaceutical manufacturing Pharmaceutical Sales Prescription Networking Pharmaceutical products Doctors More Related Topics >
article thumbnail

FDA committee set to discuss strain selection for next round of COVID-19 boosters

Fierce Pharma

JUNE 15, 2023

While demand for COVID-19 vaccines has plummeted throughout 2023, healthcare officials remain focused on ensuring that the most effective shots are available for those who need them. Now, regulators are discussing strain selection for the next round of boosters.

Healthcare 229
Healthcare Healthcare FDA 229
This site is protected by reCAPTCHA and the Google Privacy Policy and Terms of Service apply.

 

Stay Connected

Join 8,000+ Insiders by signing up for our newsletter

About
About
Editions
Editions
Topics
Powered by Aggregage | Terms and Conditions | Your California Rights and Privacy Policy
© Aggregage 2024